Rybrevant 350 mg/7 mL (50 mg/mL) injection Images

Generic Name: amivantamab

This medication has been identified as Rybrevant 350 mg/7 mL (50 mg/mL) injection. It is supplied by Janssen Biotech, Inc.

Rybrevant is used in the treatment of Non Small Cell Lung Cancer and belongs to the drug class miscellaneous bispecific antibodies. Rybrevant 350 mg/7 mL (50 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Rybrevant

Generic Name

amivantamab

Strength

350 mg/7 mL (50 mg/mL) injection

Availability

Prescription only

Drug Class

Miscellaneous bispecific antibodies

CSA Schedule

Not a controlled drug

Labeler / Supplier

Janssen Biotech, Inc.

National Drug Code (NDC)

57894-0501

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer